ATP6V1G1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.555200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.675000E-01
Normal-vs-Stage2
5.467600E-01
Normal-vs-Stage3
4.465800E-01
Normal-vs-Stage4
9.680800E-01
Stage1-vs-Stage2
3.624600E-01
Stage1-vs-Stage3
4.459600E-01
Stage1-vs-Stage4
9.404600E-01
Stage2-vs-Stage3
5.911600E-01
Stage2-vs-Stage4
5.167800E-01
Stage3-vs-Stage4
4.304800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.641600E-01
Normal-vs-AfricanAmerican
3.574000E-01
Normal-vs-Asian
9.797400E-01
Caucasian-vs-AfricanAmerican
5.188200E-01
Caucasian-vs-Asian
6.105600E-01
AfricanAmerican-vs-Asian
3.607400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.096800E-01
Normal-vs-Female
8.201400E-01
Male-vs-Female
6.530000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.735200E-01
Normal-vs-Age(41-60Yrs)
8.559800E-01
Normal-vs-Age(61-80Yrs)
5.772600E-01
Normal-vs-Age(81-100Yrs)
9.171800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.926400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.486200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.850800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.147650E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.640100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.645600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.994400E-01
Normal-vs-Daily Drinker
8.968000E-01
Normal-vs-Weekly Drinker
1.738030E-01
Normal-vs-Occasional Drinker
8.491800E-01
Normal-vs-Social Drinker
9.373000E-01
Non Drinker-vs-Daily Drinker
2.337400E-01
Non Drinker-vs-Weekly Drinker
9.709800E-01
Non Drinker-vs-Occasional Drinker
6.253900E-02
Non Drinker-vs-Social Drinker
2.560200E-01
Daily Drinker-vs-Weekly Drinker
2.414000E-01
Daily Drinker-vs-Occasional Drinker
5.482200E-01
Daily Drinker-vs-Social Drinker
9.415000E-01
Weekly Drinker-vs-Occasional Drinker
7.955500E-02
Weekly Drinker-vs-Social Drinker
3.160400E-01
Occasional Drinker-vs-Social Drinker
6.499400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.647400E-01
Normal-vs-Grade 2
5.489800E-01
Normal-vs-Grade 3
6.096800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.997160E-01
Grade 1-vs-Grade 3
7.515500E-02
Grade 1-vs-Grade 4
2.647400E-01
Grade 2-vs-Grade 3
1.353760E-01
Grade 2-vs-Grade 4
5.489800E-01
Grade 3-vs-Grade 4
6.096800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.655000E-01
Normal-vs-NonDiabetic
8.688400E-01
Diabetic-vs-NonDiabetic
5.469800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.938100E-02
Normal-vs-NoPancreatitis
7.904200E-01
Pancreatitis-vs-NoPancreatitis
1.601560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.527000E-01
Normal-vs-N1
5.934000E-01
N0-vs-N1
2.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.342400E-01
Normal-vs-TP53-NonMutant
9.880600E-01
TP53-Mutant-vs-TP53-NonMutant
4.225200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
